Moncef Slaoui, the ex-head of GlaxoSmithKline’s vaccines division, has been tapped to lead President Donald Trump’s “warp speed” effort to develop a coronavirus vaccine, two White House officials said Wednesday.
Moncef Slaoui, the ex-head of GlaxoSmithKline’s vaccines division, has been tapped to lead President Donald Trump’s “warp speed” effort to develop a coronavirus vaccine, two White House officials said Wednesday.